Author

Stamatina Danielides

Observed names: S Danielides, S J Danielides, S. Danielides, STAMATINA DANIELIDES, Stamatina J. Danielides

Institution: Virginia Commonwealth University

Observed institutions: Inova Health System, National Institutes of Health, Virginia Commonwealth University, National and Kapodistrian University of Athens, Aristotle University of Thessaloniki, Inova Fairfax Hospital, AHEPA University Hospital, National Institute of Dental and Craniofacial Research, University of Virginia, Virginia Commonwealth University Medical Center, Columbia University

OpenAlex ID: A5040755316

Early responses to adenoviral-mediated transfer of the aquaporin-1 cDNA for radiation-induced salivary hypofunction

2012 · Bruce J. Baum, Ilias Alevizos, et al. · Proceedings of the National Academy of Sciences · 196

Insulin Resistance in Rheumatoid Arthritis: Disease‐Related Indicators and Associations With the Presence and Progression of Subclinical Atherosclerosis

2014 · Jon T. Giles, Stamatina Danielides, et al. · Arthritis & Rheumatology · 109

Late responses to adenoviral-mediated transfer of the aquaporin-1 gene for radiation-induced salivary hypofunction

2016 · I Alevizos, C Zheng, et al. · Gene Therapy · 73

Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients

2021 · Antonio Abbate, Josh Gavin, et al. · International Journal of Cardiology · 63

A National Survey of Burnout and Depression Among Fellows Training in Pulmonary and Critical Care Medicine

2020 · Michelle Sharp, Kristin M. Burkart, et al. · CHEST Journal · 40

Increased Serum Type I Interferon Activity in Organ-Specific Autoimmune Disorders: Clinical, Imaging, and Serological Associations

2013 · Clio P. Mavragani, Timothy B. Niewold, et al. · Frontiers in Immunology · 29

Antithyroid antibodies in antiphospholipid syndrome: prevalence and clinical associations

2009 · CP Mavragani, S Danielides, et al. · Lupus · 18

Increased prevalence of anti-thyroid antibodies in patients with limited scleroderma

2011 · S Danielides, CP Mavragani, et al. · Scandinavian Journal of Rheumatology · 12

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease

2025 · Anahita Deboo, Robert Fox, et al. · Arthritis Care & Research · 4

Targetable immune checkpoint molecules may be significantly differentially expressed in minority ethnicities.

2020 · Jacob J. Adashek, Christopher Szeto, et al. · Journal of Clinical Oncology · 4

Recommendations for Aligned Nomenclature of Peripheral Nervous System Disorders Across Rheumatology and Neurology

2024 · Ghaith Noaiseh, Anahita Deboo, et al. · Arthritis & Rheumatology · 3

Discontinuation versus continuation of maintenance treatment with tumor necrosis factor inhibitors in patients with rheumatoid arthritis with low disease activity or remission: A randomized double-blind placebo-controlled trial

2025 · Michael M. Ward, Arthur Weinstein, et al. · Seminars in Arthritis and Rheumatism · 2

HEMANGIOPERICYTOMA IN AN ADOLESCENT GIRL: A Case Report

2004 · F. Athanassiadou, M. Kourti, et al. · Pediatric Hematology and Oncology · 2

Sarcoma-associated lichen planus–like paraneoplastic autoimmune multiorgan syndrome with colonic perforation

2021 · Fnu Nutan, Heloisa De Carvalho, et al. · JAAD Case Reports · 1

Patient-Reported Outcomes Following Discontinuation of Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis Remission/Low Disease Activity: A Randomized Placebo-Controlled Trial

2026 · Michael M. Ward, Arthur Weinstein, et al. · The Journal of Rheumatology

Ra-ild Presenting as Organizing Pneumonia and Focal Mpgn

2025 · HASSNAIN R SYED, ZEIN KATTIH, et al. · CHEST Journal

Evidence-based Guidelines for Sjögren’s Disease Peripheral Nervous System Manifestations (S38.004)

2024 · George Sarka, Anahita Deboo, et al. · Neurology

Works count: 17

Citation count: 556

H-index: 8

I10-index: 8